| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 885 | 2021 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 441 | 2021 |
| MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease PA Juge, JS Lee, E Ebstein, H Furukawa, E Dobrinskikh, S Gazal, ... New England Journal of Medicine 379 (23), 2209-2219, 2018 | 389 | 2018 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 333 | 2021 |
| Pulmonary alveolar proteinosis R Borie, C Danel, MP Debray, C Taille, MC Dombret, M Aubier, R Epaud, ... European Respiratory Review 20 (120), 98-107, 2011 | 328 | 2011 |
| Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ... Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017 | 302 | 2017 |
| Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris B Duchemann, I Annesi-Maesano, CJ de Naurois, S Sanyal, PY Brillet, ... European Respiratory Journal 50 (2), 2017 | 279 | 2017 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 275 | 2021 |
| COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study J Avouac, E Drumez, E Hachulla, R Seror, S Georgin-Lavialle, ... The Lancet Rheumatology 3 (6), e419-e426, 2021 | 250 | 2021 |
| Clinical characteristics and prognostic factors of pulmonary MALT lymphoma R Borie, M Wislez, G Thabut, M Antoine, A Rabbat, LJ Couderc, I Monnet, ... European Respiratory Journal 34 (6), 1408-1416, 2009 | 246 | 2009 |
| Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection J Frija-Masson, MP Debray, M Gilbert, FX Lescure, F Travert, R Borie, ... European Respiratory Journal 56 (2), 2020 | 242 | 2020 |
| Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort L Guglielmetti, D Le Dû, M Jachym, B Henry, D Martin, E Caumes, ... Clinical Infectious Diseases 60 (2), 188-194, 2015 | 206 | 2015 |
| Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis PA Juge, R Borie, C Kannengiesser, S Gazal, P Revy, ... European Respiratory Journal 49 (5), 2017 | 191 | 2017 |
| Methotrexate and rheumatoid arthritis associated interstitial lung disease PA Juge, JS Lee, J Lau, L Kawano-Dourado, JR Serrano, M Sebastiani, ... European Respiratory Journal 57 (2), 2021 | 175 | 2021 |
| The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population R Borie, B Crestani, P Dieude, H Nunes, Y Allanore, C Kannengiesser, ... PloS one 8 (8), e70621, 2013 | 175 | 2013 |
| Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis L Sesé, H Nunes, V Cottin, S Sanyal, M Didier, Z Carton, D Israel-Biet, ... Thorax 73 (2), 145-150, 2018 | 167 | 2018 |
| Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis C Kannengiesser, R Borie, C Ménard, M Réocreux, P Nitschké, S Gazal, ... European Respiratory Journal 46 (2), 474-485, 2015 | 162 | 2015 |
| Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases Y Allenbach, Y Uzunhan, S Toquet, G Leroux, L Gallay, A Marquet, ... Neurology 95 (1), e70-e78, 2020 | 160 | 2020 |
| Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis R Borie, L Tabèze, G Thabut, H Nunes, V Cottin, S Marchand-Adam, ... European Respiratory Journal 48 (6), 1721-1731, 2016 | 156 | 2016 |
| Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients JN Boursiquot, L Gérard, M Malphettes, C Fieschi, L Galicier, D Boutboul, ... Journal of clinical immunology 33, 84-95, 2013 | 156 | 2013 |
